Related MeSH Hierarchy (5)
Diseases [C] » Neoplasms [C04] » Neoplasms by Site » Urogenital Neoplasms » Genital Neoplasms, Female » Uterine Neoplasms » Endometrial Neoplasms
Diseases [C] » Urogenital Diseases [C12] » Female Urogenital Diseases and Pregnancy Complications » Female Urogenital Diseases » Genital Diseases, Female » Uterine Diseases » Uterine Neoplasms » Endometrial Neoplasms
Diseases [C] » Urogenital Diseases [C12] » Female Urogenital Diseases and Pregnancy Complications » Female Urogenital Diseases » Urogenital Neoplasms » Genital Neoplasms, Female » Uterine Neoplasms » Endometrial Neoplasms
Diseases [C] » Urogenital Diseases [C12] » Genital Diseases » Genital Diseases, Female » Uterine Diseases » Uterine Neoplasms » Endometrial Neoplasms
Diseases [C] » Urogenital Diseases [C12] » Urogenital Neoplasms » Genital Neoplasms, Female » Uterine Neoplasms » Endometrial Neoplasms
Description
Tumors or cancer of ENDOMETRIUM, the mucous lining of the UTERUS. These neoplasms can be benign or malignant. Their classification and grading are based on the various cell types and the percent of undifferentiated cells. MeSH
Hierarchy View
Subtype Terms (2)
Carcinoma, Endometrioid
15 drugs (9 approved, 6 experimental)
Endometrial Stromal Tumors
1 approved drug
Approved Indicated Drugs (2)
Phase 4 Indicated Drugs (14)
Phase 3 Indicated Drugs (34)
Other Experimental Indicated Drugs (16)
Organization Involved with Phase 4 Indications (3)
Organization Involved with Phase 3 Indications (65)
Arbeitsgemeinschaft Gynaekologische Onkologie Austria
Australia New Zealand Gynaecological Oncology Group
Cancer and Leukemia Group B (CALGB)
Case Western Reserve University
Ciusss de L'Est de l'Île de Montréal
Danish Gynecological Cancer Group
Eastern Cooperative Oncology Group
European Network for Gynaecological Oncological Trial
European Network for Gynaecological Oncological Trial Groups
European Organisation for Research and Treatment of Cancer
Huazhong University of Science and Technology
Institut de Cancérologie de Lorraine
Institut National de la Santé Et de la Recherche Médicale, France
Katholieke Universiteit Leuven
Nordic Society for Gynaecologic Oncology
North Eastern Germany Society of Gynaecologic Oncology
Radiation Therapy Oncology Group
Organization Involved with Phase 2 Indications (158)
Big Ten Cancer Research Consortium
Boryung Pharmaceutical Company
Catholic University of Sacred Heart, Rome
City of Hope National Medical Center
ECOG-ACRIN Cancer Research Group
European Network of Individualized Treatment in Endometrial Cancer
European Network of Translational Research in Ovarian Cancer
Florida Gynecologic Oncology, Fort Myers
Grupo Español de Investigación en Cáncer de Ovario
Herbert Irving Comprehensive Cancer Center
Hoosier Cancer Research Network
Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd
Korean Gynecologic Oncology Group
Memorial Sloan-Kettering Cancer Center
Mid-Atlantic Gynecologic Oncology & Pelvic Surgical Associates
Multicenter Italian Trials in Ovarian Cancer
National Cheng Kung University
National Comprehensive Cancer Network
People's Liberation Army of China
Royal Marsden Hospital NHS Trust
San Antonio Military Medical Center
State University of New York, Buffalo
St. Vincent Medical Center - Los Angeles
Universidad Autonoma de Barcelona
Universidad Complutense de Madrid
Université catholique de Louvain
University of Alabama, Birmingham
University of California, Davis
University of California, Los Angeles
University of Campania Luigi Vanvitelli
University of Colorado, Denver
University of North Carolina at Chapel Hill
Organization Involved with Phase 1 Indications (37)
Organization Involved with Other Experimental Indications (6)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.